The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat COVID-19, saying that the data has not shown the drug to be an effective therapeutic for ...

Short Communication Published: 23 October 2001 The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone I ...

Background: The treatment of binge eating disorder (BED) is still the object of debate. In the present study, the effectiveness of antidepressant drugs (fluoxetine–FLX–60 mg/day, fluvoxamine–FLV–300 ...

The FDA has approved once-daily Luvox CR (fluvoxamine maleate extended-release capsules, from Jazz) for the treatment of social anxiety disorder (SAD) and obsessive compulsive disorder (OCD). This ...

The FDA approved in March revisions to the safety labeling for fluvoxamine maleate tablets (made by several manufacturers, formerly marketed as Luvox by Solvay Pharmaceuticals) to advise of ...